REVIEW 1 cited by
Domain Generalization with Adversarial Intensity Attack for Medical Image Segmentation
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Most statistical learning algorithms rely on an over-simplified assumption, that is, the train and test data are independent and identically distributed. In real-world scenarios, however, it is common for models to encounter data from new and different domains to which they were not exposed to during training. This is often the case in medical imaging applications due to differences in acquisition devices, imaging protocols, and patient characteristics. To address this problem, domain generalization (DG) is a promising direction as it enables models to handle data from previously unseen domains by learning domain-invariant features robust to variations across different domains. To this end, we introduce a novel DG method called Adversarial Intensity Attack (AdverIN), which leverages adversarial training to generate training data with an infinite number of styles and increase data diversity while preserving essential content information. We conduct extensive evaluation experiments on various multi-domain segmentation datasets, including 2D retinal fundus optic disc/cup and 3D prostate MRI. Our results demonstrate that AdverIN significantly improves the generalization ability of the segmentation models, achieving significant improvement on these challenging datasets. Code is available upon publication.
Forward citations
Cited by 1 Pith paper
-
Rethink Domain Generalization in Heterogeneous Sequence MRI Segmentation
A semi-supervised pretraining method improves cross-sequence pancreas segmentation Dice from 43.55% to 70.39% (NU) and from 35.62% to 66.61% (IH) on the new PancreasDG benchmark.
Discussion (0). Sign in to comment.